Share on StockTwits
 

Quest Diagnostics (NYSE:DGX) will post its quarterly earnings results on Thursday, January 30th. Parties that are interested in registering for the company’s conference call can do so using this link.

Shares of Quest Diagnostics (NYSE:DGX) opened at 53.36 on Wednesday. Quest Diagnostics has a 52 week low of $51.90 and a 52 week high of $64.10. The stock has a 50-day moving average of $53.99 and a 200-day moving average of $58.80. The company has a market cap of $7.760 billion and a P/E ratio of 11.03.

A number of analysts have recently weighed in on DGX shares. Analysts at Zacks reiterated an “underperform” rating on shares of Quest Diagnostics in a research note to investors on Tuesday. They now have a $49.00 price target on the stock. On a related note, analysts at Maxim Group initiated coverage on shares of Quest Diagnostics in a research note to investors on Tuesday. They set a “buy” rating and a $68.00 price target on the stock. Finally, analysts at FBR Capital Markets cut their price target on shares of Quest Diagnostics from $68.00 to $60.00 in a research note to investors on Monday. They now have a “market perform” rating on the stock. Four equities research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and four have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $59.22.

Quest Diagnostics Incorporated (NYSE:DGX)is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.